Promising Companies

Also showing items for Promising Research

 
Stock Quotes for Promising Companies top ^
  • Industry: Data Storage
  • Sector: Technology
  • Stock Style: Small Growth
Sign-up for 3057 investment picks

 
News Articles for Promising Companies top ^
HILDEN , Germany and VIENNA , April 10, 2014 /PRNewswire/ -- Reliable diagnostic tools under development for mutations of calreticulin (CALR) are expected to benefit patients with blood disorders known as myeloproliferative neoplasms QIAGEN acquired exclusive worldwide license for CALR biomarker from CeMM Vienna, whose researchers recently published the discovery in the New England Journal of Medicine Addition of CALR biomarker expands market-leading position in Personalized Healthcare in blood disorders, which includes JAK2, BCR-ABL and other assays QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has acquired an exclusive worldwide license to the biomarker calreticulin (CALR), whose recently discovered mutations are found in an estimated 15% of cases of myeloproliferative neoplasms (MPNs), a group of blood disorders.
Sign-up for QIAGEN Adds Promising New Biomarker to Pipeline of Personalized Healthcare Assays to Improve Diagnosis of Blood Disorders investment picks
http://media.marketwire.com/attachments/201307/175415_Clipboard01.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1113492&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Mattersight Recognized by CIO Review as a Most Promising Big Data Company investment picks
SOUTH SAN FRANCISCO, Calif., April 7, 2014 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) , a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, today announced results from three preclinical studies related to its ongoing research and development programs.
Sign-up for OXiGENE Announces Results of Promising Preclinical Studies at 2014 AACR Conference investment picks
SYDNEY , May 2, 2014 /PRNewswire/ -- Novogen Limited (NASDAQ: NVGN, ASX: NRT;), an oncology drug development company, today announced a collaboration with Australian company, Genea Biocells, to accelerate testing of their super-benzopyran (SBP) drugs for degenerative diseases of the nervous system and muscles.
Sign-up for Novogen and Genea Announce Partnership to Investigate Promising New Approach to Neurodegenerative Diseases investment picks
2014/4/30
SAN FRANCISCO (MarketWatch) - Shares of Facebook Inc. (FB), which were up fractionally earlier in the session, rallied 2% Wednesday as the company kicked off its F8 developer conference.
Sign-up for Facebook rallies as Zuckerberg promises 'stable mobile platform' in F8 conference investment picks
2014/5/12
Small business growth is the sole focus of Sunday morning broadcast aimed at area business owners.
Sign-up for Domino's Pizza Presents Small Talk Broadcast Which Promises to Deliver Big Insights into Today's Small Business Challenges investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Promising Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Projected Revenues  |  Next: Promising Research